Literature DB >> 2909449

Gynecologic cancer in the very elderly.

A W Kennedy1, J S Flagg, K D Webster.   

Abstract

Due to the increasingly elderly population of the United States, it was elected to review the experience at the Cleveland Clinic Foundation in treating women older than 75 years of age for gynecologic cancer. The charts of 114 patients were reviewed to study the presentation of primary cancers, the morbidity and mortality associated with therapies, and patient survival. Cardiovascular disease, including hypertension, and diabetes mellitus were the most common associated medical problems. 36% of patients had endometrial cancer, 25% cervical cancer, 19% vulvar cancer, 12% ovarian cancer and 7% vaginal cancers. Compared to data for patients of all ages in Annual Report on the Results of Treatment in Gynecologic Cancer (Vol. 18), patients with endometrial, cervical, and vulvar cancers were of a significantly more advanced stage than expected. Therapy was modified due to patient age or medical status in 42 patients. No postoperative mortality was encountered, although patients often required multiple prolonged hospitalizations. The projected overall survival rate (Kaplan-Meier Analysis) was 44% at 5 years. It is concluded that despite their advanced age and associated medical problems, very elderly patients can usually receive definitive cancer therapies, including surgery, after careful preoperative medical evaluation and therapy.

Entities:  

Mesh:

Year:  1989        PMID: 2909449     DOI: 10.1016/0090-8258(89)90849-4

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

Review 1.  Drug therapy for gynaecological cancer in older women.

Authors:  R E van Rijswijk; J B Vermorken
Journal:  Drugs Aging       Date:  2000-07       Impact factor: 3.923

2.  [Geriatric surgery in gynecology].

Authors:  C Anthuber
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

3.  Pelvic exenteration: impact of age on surgical and oncologic outcomes.

Authors:  Marilyn Huang; David A Iglesias; Shannon N Westin; Bryan Fellman; Diana Urbauer; Kathleen M Schmeler; Michael Frumovitz; Pedro T Ramirez; Pamela T Soliman
Journal:  Gynecol Oncol       Date:  2013-11-18       Impact factor: 5.482

4.  Evaluating the Incidence Rate of an Accelerated Short Course High Dose Rate Intravaginal Brachytherapy Complications in Patients with Endometrial Cancer.

Authors:  Farnaz Amouzegar Hashemi; Zakieh Vesgari Kiasari; Bita Kalaghchi; Mahdi Aghili; Soraya Gholami; Sepideh Mansouri; Sepand Moalej; Afsaneh Maddah Safaei
Journal:  Asian Pac J Cancer Prev       Date:  2019-07-01

5.  Women's Knowledge on Cervical Cancer Risk Factors and Symptoms: A Cross Sectional Study from Urban India.

Authors:  Priyanka Rani Garg; Shobhit Srivastava; Shumayla Shumayla; Kauma Kurian; Ataur Rehman; Rishi Garg; Suresh Kumar Rathi; Sunil Mehra
Journal:  Asian Pac J Cancer Prev       Date:  2022-03-01

Review 6.  Age Is Not a Limiting Factor in Interventional Radiotherapy (Brachytherapy) for Patients with Localized Cancer.

Authors:  Valentina Lancellotta; György Kovács; Luca Tagliaferri; Elisabetta Perrucci; Giuseppe Colloca; Vincenzo Valentini; Cynthia Aristei
Journal:  Biomed Res Int       Date:  2018-01-21       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.